Early-set POMC methylation variability is accompanied by increased risk for obesity and is addressable by MC4R agonist treatment
Lara Lechner, R. Opitz, M. Silver, Philipp M. Krabusch, A. Prentice, M. Field, H. Stachelscheid, E. Leitão, Christopher Schröder, V. Fernandez Vallone, B. Horsthemke, K. Jöckel, B. Schmidt, M. Nöthen, P. Hoffmann, S. Herms, P. Kleyn, M. Megges, U. Blume-Peytavi, Katja Weiss, K. Mai, O. Blankenstein, B. Obermayer, S. Wiegand, Peter Kühnen
Science Translational Medicine